A multinational, randomised, 12-week, comparative study of donepezil and rivastigmine in patients with mild to moderate Alzheimer's disease

International Journal of Clinical Practice

Volumn 56, Issue 6, 2002, Pages 441-446

  Wilkinson, D G ^a   Passmore, A P ^a   Bullock, R ^a   Hopker, S W ^a   Smith, R ^a   Potocnik, F C V ^a   Maud, C M ^a   Engelbrecht, I ^a   Hock, C ^a   Ieni, J R ^a   Bahra, R S ^a  

^a MOORGREEN HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

DONEPEZIL; RIVASTIGMINE;

ADULT; AGED; ALZHEIMER DISEASE; ANOREXIA; ARTICLE; BACKACHE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DISEASE SEVERITY; DRUG LABELING; DRUG RESPONSE; DRUG TOLERABILITY; DRUG WITHDRAWAL; FEMALE; HEADACHE; HUMAN; MAJOR CLINICAL STUDY; MALE; NAUSEA; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SIDE EFFECT; SOMNOLENCE; URINARY TRACT INFECTION; VOMITING;

AGED; AGED, 80 AND OVER; ALZHEIMER DISEASE; ANALYSIS OF VARIANCE; CARBAMATES; CHOLINESTERASE INHIBITORS; FEMALE; HUMANS; INDANS; MALE; MIDDLE AGED; PHENYLCARBAMATES; PIPERIDINES; TREATMENT OUTCOME;

EID: 0036336383     PISSN: 13685031     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (22)

1. The cholinergic hypothesis of geriatric memory dysfunction
2. Selective loss of central cholinergic neurons in Alzheimer's disease
3. Necropsy evidence of central cholinergic deficits in senile dementia
4. Choline acetyltransferase activity and histopathology of frontal neocortex from biopsies of demented patients
5. The cholinergic deficit comcides with Aβ deposition at the earliest histopathologic stages of Alzheimer disease
6. The efficacy and safety of donepezil in patients with Alzheimer's disease: Results of a US multicenter, randomized, double-blind, placebo-controlled trial
7. Donepezil improves cognition and global function in Alzheimer's disease: A 15-week, double-blind, placebo-controlled study
8. A 24-week, double-blind, placebo-controlled trial of donepezil in patients with Alzheimer's disease
9. The effects of donepezil in Alzheimer's disease: Results from a multinational trial
10. A 1-year, randomized, placebo-controlled study of donepezil in patients with mild to moderate AD
11. A 1-year, placebo-controlled preservation of function survival study of donepezil in AD patients
12. Efficacy and safety of rivastigmine in patients with Alzheimer's disease: International randomised controlled trial
13. A randomized trial evaluating the efficacy and safety of ENA 713 (rivastigmine tartrate), a new acetylcholinesterase inhibitor, in patients with mild to moderately severe Alzheimer's disease
14. Rivastigmine: A review of its use in Alzheimer's disease
15. Cholinesterase inhibitors for the treatment of Alzheimer's disease in the elderly
16. Summary of product characteristics
17. Clinical diagnosis of Alzheimer's disease: Report of the NINCDS-ADRDA work group under the auspices of Department of Health and Human Services task force in Alzheimer's disease
18. 'Mini-mental state': A practical method for grading the cognitive state of subjects for the clinician
19. Aricept® (donepezil hydrochloride) tablets. Package insert
20. Exelon® (rivastigmine tartrate) capsules prescribing information
21. A new rating scale for Alzheimer's disease